Evidence map›Paper›PMID 30481275›Full record

ArticleAmerican journal of epidemiology2019

Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition.

Laura Costas, Leila Lujan-Barroso, Yolanda Benavente, Naomi E Allen, Pilar Amiano, Eva Ardanaz, Caroline Besson, Heiner Boeing, Bas Bueno-de-Mesquita, Iris Cervenka and 32 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in American journal of epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Increased Risk of Lymphoma in Men or the Elderly Infected with Tuberculosis.Mediterranean journal of hematology and infectious diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 13 countries.

Laura CostasUnit of Molecular Epidemiology and Genetics in Infections and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
Leila Lujan-BarrosoUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
Yolanda BenaventeUnit of Molecular Epidemiology and Genetics in Infections and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
Naomi E AllenClinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
Pilar AmianoConsortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
Eva ArdanazConsortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
Caroline BessonUnit of Hematology-Oncology, Centre Hospitalier de Versailles, Le Chesnay, France.
Heiner BoeingGerman Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Bas Bueno-de-MesquitaDepartment of Determinants of Chronic Diseases, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Iris CervenkaCentre de Recherche en Epidémiologie et Santé des Populations, Faculté de Médecine-Université Paris-Sud and Faculté de Médecine-Université de Versailles Saint-Quentin-en-Yvelines, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Villejuif, France.
Renée T FortnerDivision of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Agnès FournierCentre de Recherche en Epidémiologie et Santé des Populations, Faculté de Médecine-Université Paris-Sud and Faculté de Médecine-Université de Versailles Saint-Quentin-en-Yvelines, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Villejuif, France.
Marc GunterInternational Agency for Research on Cancer, Lyon, France.
Sophia HarlidDepartment of Radiation Sciences, Oncology, Faculty of Medicine, Umeå University, Umeå, Sweden.
José María HuertaConsortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
Mats JerkemanDivision of Oncology and Pathology, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
Karin JirströmDivision of Oncology and Pathology, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Anna KarakatsaniHellenic Health Foundation, Athens, Greece.
Kay-Tee KhawDepartment of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Anastasia KotanidouHellenic Health Foundation, Athens, Greece.
Eiliv LundDepartment of Community Medicine, The Arctic University of Norway, Tromsø, Norway.
Giovanna MasalaCancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy.
Amalia MattielloDipartimento di Medicina Clinica e Chirugia, Federico II University, Naples, Italy.
Beatrice MelinDepartment of Radiation Sciences, Oncology, Faculty of Medicine, Umeå University, Umeå, Sweden.
Virginia MenéndezPublic Health Directorate, Asturias, Spain.
Neil MurphyInternational Agency for Research on Cancer, Lyon, France.
Alexandra NietersCenter for Chronic Immunodeficiency at the Center for Translational Cell Research, University of Freiburg Medical Center, Freiburg, Germany.
Kim OvervadDepartment of Public Health, Faculty of Health, Aarhus University, Aarhus, Denmark.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention, Turin, Italy.
Maria-Jose SánchezConsortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
Julie A SchmidtCancer Epidemiology Unit, Nuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
Sabina SieriEpidemiology and Prevention Unit, Fondazione IRCCS-Istituto Nazionale dei Tumori, Milano, Italy.
Anne TjønnelandDiet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Rosario TuminoCancer Registry and Histopathology Department, Maria Paternò Arezzo Hospital, Ragusa, Italy.
Roel VermeulenDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
Elisabete WeiderpassDepartment of Community Medicine, The Arctic University of Norway, Tromsø, Norway.
Silvia de SanjoséPATH, Seattle, Washington.
Antonio AgudoUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
Delphine CasabonneUnit of Molecular Epidemiology and Genetics in Infections and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
Bellvitge University Hospital · ESUniversité Paris-Sud · FRCentre international de recherche sur le cancer · FRGerman Cancer Research Center · DELund University · SENational and Kapodistrian University of Athens · GRUmeå University · SEUniversity of Oxford · GBAarhus University · DKAzienda Usl 8 Arezzo · ITBiogipuzkoa Health Research Institute · ESDanish Cancer Society · DKFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Institute of Human Nutrition · DEGobierno del Principado de Asturias · ESHellenic Health Foundation · GRImperial College London · GBInstituto de Salud Pública de Navarra · ESInstituto Murciano de Investigación Biosanitaria · ES

Funding

Cancer Research UK 14136Cancer Research UK 16491Cancer Research UK C570/A16491Cancer Research UK C8221/A19170Medical Research Council MR/M012190/1World Health Organization 001
6 · The paper itself

Abstract

The role of hormonal factors in the etiology of lymphoid neoplasms remains unclear. Previous studies have yielded conflicting results, have lacked sufficient statistical power to assess many lymphoma subtypes, or have lacked detailed information on relevant exposures. Within the European Prospective Investigation Into Cancer and Nutrition cohort, we analyzed comprehensive data on reproductive factors and exogenous hormone use collected at baseline (1992-2000) among 343,458 women, including data on 1,427 incident cases of B-cell non-Hodgkin lymphoma (NHL) and its major subtypes identified after a mean follow-up period of 14 years (through 2015). We estimated hazard ratios and 95% confidence intervals using multivariable proportional hazards modeling. Overall, we observed no statistically significant associations between parity, age at first birth, breastfeeding, oral contraceptive use, or ever use of postmenopausal hormone therapy and risk of B-cell NHL or its subtypes. Women who had undergone surgical menopause had a 51% higher risk of B-cell NHL (based on 67 cases) than women with natural menopause (hazard ratio = 1.51, 95% confidence interval: 1.17, 1.94). Given that this result may have been due to chance, our results provide little support for the hypothesis that sex hormones play a role in lymphomagenesis.

Indexed as

Reproductive HistoryBreast FeedingEstrogen Replacement TherapyEuropeFemaleHumansLymphoma, B-CellProportional Hazards ModelsProspective StudiesRisk FactorsWomen's Health

Identifiers

PMID30481275
PMCPMC6357796
OpenAlexW2903775650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.